Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2004

FR Doc 04-23053 [Federal Register: October 14, 2004 (Volume 69, Number 198)] [Notices] [Page 61043-61044] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr14oc04-100]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to 21 CFR 1301.33(a), this is notice that on July 6, 2004, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed:

[[Page 61044]]

DRUG SCHEDULE
Cathinone (1235) I
Methcathinone (1237) I
N-Ethylamphetamine (1475) I
N,N-Dimethylamphetamine (1480) I
Aminorex (1585) I
4-Methylaminorex (cis isomer) (1590) I
Gamma hydroxybutyric acid (2010) I
Methaqualone (2565) I
Alpha-Ethyltryptamine (7249) I
Lysergic acid diethylamide (7315) I
Tetrahydrocannabinols (7370) I
Mescaline (7381) I
3,4,5-Trimethoxyamphetamine (7390) I
4-Bromo-2,5-dimethoxyamphetamine (7391) I
4-Bromo-2,5-dimethoxyphenethylamine (7392) I
4-Methyl-2,5-dimethoxyamphetamine (7395) I
2,5-Dimethoxyamphetamine (7396) I
2,5-Dimethoxy-4-ethylamphetamine (7399) I
3,4-Methylenedioxyamphetamine (7400) I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) I
N-Hydroxy-3,4-methylendioxyamphetamine (7402) I
3,4-Methylendioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymetham- phetamine (7405) I
4-Methoxyamphetamine (7411) I
Bufotenine (7433) I
Diethyltryptamine (7434) I
Heroin (9200) I
Hydromorphinol (9301) I
Methyldihydromorphine (9304) I
Morphine-N-oxide (9307) I
Normorphine (9313) I
Pholcodine (9314) I
Acetylmethadol (9601) I
Allylprodine (9602) I
Alphacetylmethadol except levo-alphacetylmethadol (9603) I
Alphameprodine (9604) I
Alphamethadol (9605) I
Betacetylmethadol (9607) I
Betameprodine (9608) I
Hydroxypethidine (9627) I
Noracymethadol (9633) I
Normethadone (9635) I
Trimeperidine (9646) I
Phenomorphan (9647) I
Para-Fluorofentanyl (9812) I
3-Methylfentanyl (9813) I
Alpha-Methylfentanyl (9814) I
Acetyl-alpha-methylfentanyl (9815) I
Beta-hydroxyfentanyl (9830) I
Beta-hydroxy-3-methylfentanyl (9831) I
Alpha-Methylthiofentanyl (9832) I
3-Methylthiofentanyl (9833) I
Thiofentanyl (9835) I
Amphetamine (1100) II
Methamphetamine (1105) II
Phenmetrazine (1631) II
Methylphenidate (1724) II
Phenmetrazine (1631) II
Methylphenidate (1724) II
Ambobarbital (2125) II
Pentobarbital (2270) II
Secobarbital (2315) II
Glutethimide (2550) II
Nabilone (7379) II
1-Phenylcyclohexylamine (7460) II
Phencyclidine (7471) II
1-Piperidinocyclohexane- carbonitrile (8603) II
Alphaprodine (9010) II
Cocaine (9041) II
Codeine (9050) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Benzoylecgonine (9180) II
Ethylmorphine (9190) II
Hydrocodone (9193) II
Levomethorphan (9210) II
Levorphanol (9220) II
Isomethadone (9226) II
Meperidine (9230) II
Methadone (9250) II
Methadone-intermediate (9254) II
Dextropropoxyphene, bulk (non-dosage forms) (9273) II
Morphine (9300) II
Thebaine (9333) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II
Noroxymorphone (9668) II
Racemethorphan (9732) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II

The company plans to manufacture small quantities of the listed controlled substances to make reference standards for distribution to their customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a)

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD) and must be filed no later than December 13, 2004.

Dated: September 28, 2004. 

William J. Walker, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. 

[FR Doc. 04-23053 Filed 10-13-04; 8:45 am]

BILLING CODE 4410-09-P

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility